Biotech Co. Wants To Appeal Red Cross Antitrust Immunity

By Matthew Perlman · May 6, 2024, 8:35 PM EDT

A biotech company has told a Massachusetts federal court that giving the American Red Cross immunity from claims that it smothered competition in the platelet bacteria mitigation market is unprecedented and...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Verax Biomedical Inc. v. American National Red Cross

Case Number

1:23-cv-10335

Court

Massachusetts

Nature of Suit

Anti-Trust

Date Filed

February 14, 2023